Citation Impact
Citing Papers
Complement and microglia mediate early synapse loss in Alzheimer mouse models
2016 StandoutScience
Inhibition of calcium-independent phospholipase A2 activity in rat hippocampus impairs acquisition of short- and long-term memory
2005
Chronic Administration of Docosahexaenoic Acid Ameliorates the Impairment of Spatial Cognition Learning Ability in Amyloid β–Infused Rats
2005
The Ubiquitin Proteasome System in Neurodegenerative Diseases
2003 StandoutNobel
α-Synuclein and the Lewy body disorders
2001
Neuropathology of the recessive A673V APP mutation: Alzheimer disease with distinctive features
2010
Role of ROS and RNS Sources in Physiological and Pathological Conditions
2016 Standout
Mutant presenilins specifically elevate the levels of the 42 residue β-amyloid peptide in vivo: evidence for augmentation of a 42-specific γ secretase
2003
Pathological roles of MAPK signaling pathways in human diseases
2010 Standout
Cellular Membrane Composition Defines Aβ-Lipid Interactions
2001
Membrane Disordering Effects of β-Amyloid Peptides
2006
Classification and basic pathology of Alzheimer disease
2009
Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects
2020 Standout
SCA17, a novel autosomal dominant cerebellar ataxia caused by an expanded polyglutamine in TATA-binding protein
2001
Role of α-synuclein in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in mice
2003 StandoutNobel
Amyloid β‐peptide interactions with neuronal and glial cell plasma membrane: binding sites and implications for Alzheimer's disease
2004
The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years
2008 Standout
TREM2 Lipid Sensing Sustains the Microglial Response in an Alzheimer’s Disease Model
2015 Standout
Immune attack: the role of inflammation in Alzheimer disease
2015 Standout
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
2019 Standout
A neurological disease caused by an expanded CAG trinucleotide repeat in the TATA-binding protein gene: a new polyglutamine disease? [In Process Citation]
1999
Cortical Lewy body pathology in the diagnosis of dementia
2001
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
2009 Standout
Statin effects on cholesterol micro-domains in brain plasma membranes
2003
Blood protein predictors of brain amyloid for enrichment in clinical trials?
2015 StandoutNobel
The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication
2020 Standout
Copper-Zinc Superoxide Dismutase (SOD1) Is Released by Microglial Cells and Confers Neuroprotection against 6-OHDA Neurotoxicity
2012 Standout
Neuropathological Alterations in Alzheimer Disease
2011 Standout
Patterns and severity of vascular amyloid in Alzheimer’s disease associated with duplications and missense mutations in APP gene, Down syndrome and sporadic Alzheimer’s disease
2018
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence
2004 Standout
DOCOSAHEXAENOIC ACID‐INDUCED PROTECTIVE EFFECT AGAINST IMPAIRED LEARNING IN AMYLOID β‐INFUSED RATS IS ASSOCIATED WITH INCREASED SYNAPTOSOMAL MEMBRANE FLUIDITY
2006
The Influence of Exercise on Cognitive Abilities
2012 Standout
The cerebellar cognitive affective syndrome
1998 Standout
Linkage of schizophrenia with chromosome 1q loci in Taiwanese families
2003
Intracellular amyloid-β in Alzheimer's disease
2007 Standout
The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia
2003 Standout
Pharmacological Properties and Molecular Mechanisms of Thymol: Prospects for Its Therapeutic Potential and Pharmaceutical Development
2017 Standout
Development of Beta-Amyloid-induced Neurodegeneration in Alzheimer's Disease and Novel Neuroprotective Strategies
2005
Imaging β-amyloid burden in aging and dementia
2007
The neuropathological diagnosis of Alzheimer’s disease
2019 Standout
Inhibition of Toll-like Receptor and Cytokine Signaling—A Unifying Theme in Ischemic Tolerance
2004 StandoutNobel
Phospholipase A2Enzymes: Physical Structure, Biological Function, Disease Implication, Chemical Inhibition, and Therapeutic Intervention
2011 Standout
Works of N.J. Cairns being referenced
Cholesterol Modulates the Membrane- Disordering Effects of Beta-Amyloid Peptides in the Hippocampus: Specific Changes in Alzheimer’s Disease
2000
The Spatial Patterns of Lewy Bodies, Senile Plaques, and Neurofibrillary Tangles in Dementia with Lewy Bodies
1998
Beta-Amyloid Deposition in the Temporal Lobe of Patients with Dementia with Lewy Bodies: Comparison with Non-Demented Cases and Alzheimer’s Disease
2000
Cases of Alzheimer's disease due to deletion of exon 9 of the presenilin‐1 gene show an unusual but characteristic β‐amyloid pathology known as ‘cotton wool’ plaques
2001
No evidence for expanded polyglutamine sequences in bipolar disorder and schizophrenia
1997